For this episode we’re joined by Cosmo Feilding Mellen, CEO of Beckley Psytech.
Born out of the Beckley Foundation – a world-renowned organisation who have been central to drug policy reform and research into psychoactive substances for over two decades – Cosmo and his team are at the forefront of modern-day psychedelic science.
With clinical trials currently in play and a bulging war chest following an oversubscribed Series B funding round, tune in to hear what’s being cooked up at Beckley HQ and more.
You can check out other podcasts on the GCI Content Hub by clicking here.
Alternatively, you can subscribe to the podcast on Apple/iTunes, Spotify and other podcasting apps!
